Tomonori Oura

Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial

Nobuya Inagaki, Masakazu Takeuchi, Tomonori Oura et al. · The Lancet Diabetes & Endocrinology · 2022 · 211 citations

Medicine, Pharmacology, Pharmacotherapy +15

Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes

Ken Yamaguchi, Masaki Mandai, Tomonori Oura et al. · Oncogene · 2010 · 184 citations

Medicine, Cancer Biology, Oncology +14

Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm

Hiromitsu Negoro, Akihiro Kanematsu, Masao Doi et al. · Nature Communications · 2012 · 143 citations · Full text

Life Sciences, Physiology, Urology +16

Single amino acid residue as a functional determinant of rod and cone visual pigments

Hiroo Imai, Daisuke Kojima, Tomonori Oura et al. · Proceedings of the National Academy of Sciences · 1997 · 137 citations

Life Sciences, Biochemistry, Molecular Biology +14

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study

Nobuya Inagaki, Yoshihito Atsumi, Tomonori Oura et al. · Clinical Therapeutics · 2012 · 84 citations

Medicine, Pharmacology, Pharmacotherapy +16